Quick filters
- Lorus Therapeutics Signs Research and License Option Agreement with Elanco Marketwire | Wednesday April 17, 2013 7:00AM
- Lorus Therapeutics Signs Research and License Option Agreement With Elanco GlobeNewswire | Wednesday April 17, 2013 4:00AM
- Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual Meeting Marketwire | Tuesday February 12, 2013 7:00AM
- Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E Marketwire | Tuesday January 22, 2013 7:00AM
- Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2013 Marketwire | Monday January 14, 2013 7:38PM
- Lorus Therapeutics Announces Successful Dose Escalation of Its Phase I Clinical Trial of LOR-253 and Initiation of a Biomarker Clinical Study in Cancer Patients Marketwire | Monday January 7, 2013 7:00AM
- Lorus Therapeutics and Brock University Sign Collaboration Agreement to Develop Novel Anticancer Drugs Marketwire | Tuesday December 18, 2012 7:00AM
- Lorus Therapeutics Announces Positive Anticancer Data for IL-17E at AACR Tumor Immunology Conference Marketwire | Tuesday December 4, 2012 7:00AM
- Lorus Therapeutics 2012 Annual and Special Meeting of Shareholders Announcement Marketwire | Wednesday November 28, 2012 7:00AM
- IIROC Trade Resumption - Lorus Therapeutics Inc. newsfile | Tuesday November 27, 2012 10:47AM
- IIROC Trade Resumption - LOR CNW Group | Tuesday November 27, 2012 10:43AM
- Cancer Research UK and Lorus to Co-Develop First-Of-Kind Drug, IL-17E, to Treat Solid Tumours Marketwire | Tuesday November 27, 2012 10:30AM
- IIROC Trade Halt - Lorus Therapeutics Inc. newsfile | Tuesday November 27, 2012 9:49AM
- IIROC Trading Halt - LOR (all issues) CNW Group | Tuesday November 27, 2012 9:45AM
- Lorus Therapeutics Reports First Quarter Results for Fiscal 2013 Marketwire | Monday October 15, 2012 5:00PM
- Lorus Therapeutics to Present at BioContact 2012 in Quebec City Marketwire | Wednesday October 3, 2012 7:00AM
- Lorus Therapeutics Receives Funding from the Government of Canada for Development of Cancer Therapy IL-17E Marketwire | Wednesday August 29, 2012 8:03AM
- Lorus Therapeutics to Present at the 14th Annual Rodman & Renshaw Healthcare Conference in New York Marketwire | Monday August 27, 2012 7:00AM
- Lorus Therapeutics Announces Issuance of Patent in Japan for Anticancer Drug LOR-253 and Antimicrobial Drug LOR-220 Marketwire | Tuesday August 14, 2012 7:00AM
- Lorus Therapeutics Reports Results for Fiscal Year 2012 Marketwire | Wednesday August 8, 2012 7:00AM
Live Discussion of LOR on StockTwits